Drugs / RJ4287
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05921006 | Jun → Dec 2023 | — | Nanjing Ruijie Pharma Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RJ4287 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05921006 ↗ |
| Route | Oral | “Oral，tablets，Once daily for 14 days” NCT05921006 ↗ |